109 related articles for article (PubMed ID: 16515603)
1. Is there a role for neoadjuvant chemotherapy in the treatment of stage IV serous endometrial carcinoma?
Despierre E; Moerman P; Vergote I; Amant F
Int J Gynecol Cancer; 2006; 16 Suppl 1():273-7. PubMed ID: 16515603
[TBL] [Abstract][Full Text] [Related]
2. Treatment of uterine papillary serous carcinoma with platinum-based chemotherapy and paclitaxel.
Vaidya AP; Littell R; Krasner C; Duska LR
Int J Gynecol Cancer; 2006; 16 Suppl 1():267-72. PubMed ID: 16515602
[TBL] [Abstract][Full Text] [Related]
3. Weekly topotecan in a heavily pretreated patient with peritoneal papillary serous adenocarcinoma.
Evans J
Int J Gynecol Cancer; 2004; 14(3):540-2. PubMed ID: 15228430
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of extensive cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with advanced epithelial ovarian cancer.
Ansaloni L; Agnoletti V; Amadori A; Catena F; Cavaliere D; Coccolini F; De Iaco P; Di Battista M; Framarini M; Gazzotti F; Ghermandi C; Kopf B; Saponara M; Tauceri F; Vallicelli C; Verdecchia GM; Pinna AD
Int J Gynecol Cancer; 2012 Jun; 22(5):778-85. PubMed ID: 22572845
[TBL] [Abstract][Full Text] [Related]
5. Postoperative external beam radiation therapy and concurrent cisplatin followed by carboplatin/paclitaxel for stage III (FIGO 2009) endometrial cancer.
Milgrom SA; Kollmeier MA; Abu-Rustum NR; Tew WP; Sonoda Y; Barakat RR; Alektiar KM
Gynecol Oncol; 2013 Sep; 130(3):436-40. PubMed ID: 23800696
[TBL] [Abstract][Full Text] [Related]
6. Survivin expression as a prognostic factor in patients with epithelial ovarian cancer or primary peritoneal cancer treated with neoadjuvant chemotherapy.
Gąsowska-Bodnar A; Bodnar L; Dąbek A; Cichowicz M; Jerzak M; Cierniak S; Kozłowski W; Baranowski W
Int J Gynecol Cancer; 2014 May; 24(4):687-96. PubMed ID: 24662134
[TBL] [Abstract][Full Text] [Related]
7. Interval between debulking surgery and adjuvant chemotherapy is associated with overall survival in patients with advanced ovarian cancer.
Timmermans M; van der Aa MA; Lalisang RI; Witteveen PO; Van de Vijver KK; Kruitwagen RF; Sonke GS
Gynecol Oncol; 2018 Sep; 150(3):446-450. PubMed ID: 30001834
[TBL] [Abstract][Full Text] [Related]
8. Skin metastasis in ovarian carcinoma.
Yilmaz Z; Bese T; Demirkiran F; Ilvan S; Sanioglu C; Arvas M; Kosebay D
Int J Gynecol Cancer; 2006; 16 Suppl 1():414-8. PubMed ID: 16515636
[TBL] [Abstract][Full Text] [Related]
9. A phase I study of IV doxorubicin plus intraperitoneal (IP) paclitaxel and IV or IP cisplatin in endometrial cancer patients at high risk for peritoneal failure (GOG 9920): an NRG Oncology/Gynecologic Oncology Group study.
McMeekin DS; Sill MW; Walker JL; Moore KN; Waggoner SE; Thaker PH; Rizack T; Hoffman JS; Fracasso PM
Gynecol Oncol; 2015 Jul; 138(1):36-40. PubMed ID: 25958319
[TBL] [Abstract][Full Text] [Related]
10. Serous peritoneal psammocarcinoma with an aggressive course: a case and review of the literature.
Bodnar L; Wcislo G; Górnas M; Gasowska-Bodnar A; Wiśniewski P; Stec R; Baranowski W; Szczylik C
Ginekol Pol; 2009 Aug; 80(8):632-6. PubMed ID: 19824465
[TBL] [Abstract][Full Text] [Related]
11. Increased incidence of severe gastrointestinal events with first-line paclitaxel, carboplatin, and vorinostat chemotherapy for advanced-stage epithelial ovarian, primary peritoneal, and fallopian tube cancer.
Mendivil AA; Micha JP; Brown JV; Rettenmaier MA; Abaid LN; Lopez KL; Goldstein BH
Int J Gynecol Cancer; 2013 Mar; 23(3):533-9. PubMed ID: 23385285
[TBL] [Abstract][Full Text] [Related]
12. Five-year outcomes of adjuvant carboplatin/paclitaxel chemotherapy and intravaginal radiation for stage I-II papillary serous endometrial cancer.
Kiess AP; Damast S; Makker V; Kollmeier MA; Gardner GJ; Aghajanian C; Abu-Rustum NR; Barakat RR; Alektiar KM
Gynecol Oncol; 2012 Nov; 127(2):321-5. PubMed ID: 22850412
[TBL] [Abstract][Full Text] [Related]
13. Feasibility study of neoadjuvant chemotherapy followed by interval debulking surgery for stage III/IV ovarian, tubal, and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0206.
Onda T; Kobayashi H; Nakanishi T; Hatae M; Iwasaka T; Konishi I; Shibata T; Fukuda H; Kamura T; Yoshikawa H
Gynecol Oncol; 2009 Apr; 113(1):57-62. PubMed ID: 19181369
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant chemotherapy followed by interval debulking surgery for unresectable stage IVB Serous endometrial cancer.
Bogani G; Ditto A; Leone Roberti Maggiore U; Scaffa C; Mosca L; Chiappa V; Martinelli F; Lorusso D; Raspagliesi F
Tumori; 2019 Feb; 105(1):92-97. PubMed ID: 29984612
[TBL] [Abstract][Full Text] [Related]
15. Endometrial carcinoma with laparotomy wound recurrence: complete remission following surgery and chemotherapy consisting of paclitaxel and carboplatin.
Gücer F; Oz-Puyan F; Yilmaz O; Mülayim N; Balkanli-Kaplan P; Yüce MA
Int J Gynecol Cancer; 2005; 15(6):1195-8. PubMed ID: 16343212
[TBL] [Abstract][Full Text] [Related]
16. Advanced ovarian cancer: phase III randomized study of sequential cisplatin-topotecan and carboplatin-paclitaxel vs carboplatin-paclitaxel.
Hoskins P; Vergote I; Cervantes A; Tu D; Stuart G; Zola P; Poveda A; Provencher D; Katsaros D; Ojeda B; Ghatage P; Grimshaw R; Casado A; Elit L; Mendiola C; Sugimoto A; D'Hondt V; Oza A; Germa JR; Roy M; Brotto L; Chen D; Eisenhauer EA
J Natl Cancer Inst; 2010 Oct; 102(20):1547-56. PubMed ID: 20937992
[TBL] [Abstract][Full Text] [Related]
17. Stage IVB endometrial carcinoma: the role of cytoreductive surgery and determinants of survival.
Bristow RE; Zerbe MJ; Rosenshein NB; Grumbine FC; Montz FJ
Gynecol Oncol; 2000 Aug; 78(2):85-91. PubMed ID: 10926785
[TBL] [Abstract][Full Text] [Related]
18. Complete remission of an endometrial carcinoma with bilateral multiple pulmonary and extrapelvic metastases treated by surgery and chemotherapy consisting of paclitaxel and carboplatin.
Gücer F; Yilmaz O; Balkanli-Kaplan P; Ali Yüce M
Int J Gynecol Cancer; 2005; 15(6):1160-2. PubMed ID: 16343202
[TBL] [Abstract][Full Text] [Related]
19. Phase III trial of upfront debulking surgery versus neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0602.
Onda T; Matsumoto K; Shibata T; Sato A; Fukuda H; Konishi I; Kamura T; Yoshikawa H;
Jpn J Clin Oncol; 2008 Jan; 38(1):74-7. PubMed ID: 18258715
[TBL] [Abstract][Full Text] [Related]
20. Primary psammocarcinoma of the peritoneum.
Bilgin T; Ozuysal S; Cankiliç H
Int J Gynecol Cancer; 2006; 16 Suppl 1():129-31. PubMed ID: 16515580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
